• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Future of HBV?

anonymous

Guest
TDF going generic. Plans are already notifying patients that only TDF, ETV or LAM (seriously...LAM!) will be approved vs. TAF in 2018. Cure not for at least 10 years. Are we sitting ducks?
 




















Similar threads